Description
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
Article: Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
€2.42
€2.42
Targeting driver mutations in non-small-cell lung cancer, beyond the usual suspects (EGFR and ALK)
Top